Malachite Innovations, Inc. VBIO OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

35/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Malachite Innovations, Inc. (VBIO) generated $964.82K in operating cash flow for quarter ending 2025-09-30. After capital expenditures of $0.00, free cash flow was $964.82K.

Free cash flow margin was 123.9% of revenue. Cash conversion ratio was 0.2x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
MOAT (25/100, Fail) — limited free cash flow weakens the competitive position
INCOME (?/100) — Cash conversion ratio was 0.2x suggests some earnings are non-cash items

Overall SharesGrow Score: 32/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

35/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

25/100

Proven by this page

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Malachite Innovations, Inc. Cash Flow History

Metric	TTM	Q2 FY2026	Q3 FY2021	Q2 FY2021	Q1 FY2021
Operating Cash Flow	$-538.22K	$964.82K	$-383.01K	$-562.7K	$-557.33K
Capital Expenditure	$0.00	$0.00	$0.00	$0.00	$0.00
Free Cash Flow	$-538.22K	$964.82K	$-383.01K	$-562.7K	$-557.33K